Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
99.97
+2.74 (2.82%)
At close: Oct 23, 2025, 4:00 PM EDT
99.00
-0.97 (-0.97%)
After-hours: Oct 23, 2025, 7:12 PM EDT
Illumina Market Cap
Illumina has a market cap or net worth of $15.37 billion as of October 23, 2025. Its market cap has decreased by -30.90% in one year.
Market Cap
15.37B
Enterprise Value
16.82B
1-Year Change
-30.90%
Ranking
Category
Stock Price
$99.97
Market Cap Chart
Since July 28, 2000, Illumina's market cap has increased from $1.24B to $15.37B, an increase of 1,144.22%. That is a compound annual growth rate of 10.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 15.37B | -27.50% |
| Dec 31, 2024 | 21.19B | -4.15% |
| Dec 29, 2023 | 22.11B | -30.48% |
| Dec 30, 2022 | 31.81B | -46.51% |
| Dec 31, 2021 | 59.46B | 10.08% |
| Dec 31, 2020 | 54.02B | 10.77% |
| Dec 31, 2019 | 48.77B | 10.61% |
| Dec 31, 2018 | 44.09B | 38.21% |
| Dec 29, 2017 | 31.90B | 69.60% |
| Dec 30, 2016 | 18.81B | -33.07% |
| Dec 31, 2015 | 28.10B | 7.21% |
| Dec 31, 2014 | 26.21B | 87.51% |
| Dec 31, 2013 | 13.98B | 104.45% |
| Dec 31, 2012 | 6.84B | 84.71% |
| Dec 30, 2011 | 3.70B | -53.27% |
| Dec 31, 2010 | 7.92B | 106.38% |
| Dec 31, 2009 | 3.84B | 19.06% |
| Dec 31, 2008 | 3.22B | -0.56% |
| Dec 31, 2007 | 3.24B | 77.31% |
| Dec 29, 2006 | 1.83B | 215.10% |
| Dec 30, 2005 | 580.20M | 60.72% |
| Dec 31, 2004 | 361.00M | 55.87% |
| Dec 31, 2003 | 231.60M | 111.51% |
| Dec 31, 2002 | 109.50M | -71.10% |
| Dec 31, 2001 | 378.90M | -26.13% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.35B |
| Johnson & Johnson | 464.66B |
| AbbVie | 403.98B |
| UnitedHealth Group | 327.39B |
| AstraZeneca | 259.95B |
| Novartis AG | 255.24B |
| Novo Nordisk | 237.27B |
| Abbott Laboratories | 222.69B |